(19)
(11) EP 2 814 834 A1

(12)

(43) Date of publication:
24.12.2014 Bulletin 2014/52

(21) Application number: 13707493.6

(22) Date of filing: 13.02.2013
(51) International Patent Classification (IPC): 
C07J 63/00(2006.01)
A61K 31/575(2006.01)
A61K 31/58(2006.01)
A61P 31/18(2006.01)
(86) International application number:
PCT/US2013/025897
(87) International publication number:
WO 2013/123019 (22.08.2013 Gazette 2013/34)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 15.02.2012 US 201261599040 P
06.02.2013 US 201313760726

(71) Applicant: Bristol-Myers Squibb Company
Princeton, NJ 08543 (US)

(72) Inventors:
  • SWIDORSKI, Jacob
    Wallingford, Connecticut 06492 (US)
  • MEANWELL, Nicholas A.
    Wallingford, Connecticut 06492 (US)
  • REGUEIRO-REN, Alicia
    Wallingford, Connecticut 06492 (US)
  • SIT, Sing-Yuen
    Wallingford, Connecticut 06492 (US)
  • CHEN, Jie
    Wallingford, Connecticut 06492 (US)
  • CHEN, Yan
    Wallingford, Connecticut 06492 (US)

(74) Representative: Reitstötter Kinzebach 
Patentanwälte Sternwartstrasse 4
81679 München
81679 München (DE)

   


(54) C-3 CYCLOALKENYL TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY